However, it is unclear how gene rearrangements or fusions involving BCL2 and MYC (key hallmarks of HGBCL), BCL6 rearrangements, and their interaction with racial backgrounds drive DLBCL pathogenesis and prognosis. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.